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Asthma is the most common chronic disease of South 
African children, affecting 10-20% of the population. 
Correct treatment of chronic asthma with regular anti-
inflammatory controller therapy prevents symptoms, 
asthma exacerbations, hospitalisation and mortality.
Modern treatment of asthma focuses on an assessment of 
asthma control in order to enable the child to lead a normal 
life by:
•	 Growing and developing normally
•	 Attending school regularly
•	 Sleeping well at night
•	 Participating in sport and activities
•	 Staying out of hospital.
With good controller treatment, less acute attacks of 
severe asthma will take place. However, to ensure fewer 
hospitalisations and less mortality, optimal treatment of 
acute attacks by families and health care professionals is 
critical.
Prompt treatment of acute severe asthma is very important. 
Asthma is a preventable cause of childhood death. Parents 
and children must know exactly what to do when an acute 
attack occurs, and when to seek medical attention. This 
is very important if the child is using a home nebuliser as 
many parents continue to administer dose after dose of 
bronchodilator medication that does not provide oxygen. 
Failure to improve after a single dose of bronchodilator, or a 
peak flow reading that is 30% below the expected level, are 
indications for hospital admission.
All children who have life-threatening asthma, or those with 
oxygen saturations < 94%, should receive high-flow oxygen 
via a mask or nasal prong oxygen to obtain saturations 
≥ 95%. Other indicators of a severe attack include 
tachycardia (bradycardia preterminally), tachypnoea, 
volume of wheezing (silent chest due to no/minimal air 
entry), decreased level of consciousness or agitation, use 
of accessory respiration muscles, pulsus paradoxus and 
inability to talk or feed due to breathlessness.
Inhaled short-acting ß
2-agonists should be started as early 
as possible in an exacerbation. The bronchodilator may 
be given by means of a nebuliser, or with a metered dose 
inhaler and spacer combination. A metered dose inhaler 
given via a spacer is more effective, as well as more cost-
effective than the nebuliser, provided that the patient is 
not acutely dyspnoeic, and that the medication is given 
in an adequate dosage. A usual dose of salbutamol via a 
nebuliser is 1.25-2.5 mg, and each dose of salbutamol via 
a metered dose inhaler is only 100 µg, so more puffs than 
usual of the metered dose inhaler are required to achieve 
an equivalent, or superior clinical effect, to a nebuliser (at 
doses that are still lower than that given via the nebuliser).
For very mild symptoms two to four puffs of a short-acting 
ß2-agonist actuated into the spacer may be sufficient, but 
for mild-moderate asthma exacerbations (attacks) a higher 
dose is required. For children below four years old, six puffs 
may be recommended, but children who are older than 
four should receive 10 puffs for asthma attacks. The puffs 
should not be actuated all at once, but at intervals of about 
10 seconds between puffs, and at least five breaths of tidal 
breathing should follow each actuation (Figure 1).
If the acute asthma attack is severe or life-threatening, the 
short-acting ß2-agonist should be administered at intervals 
of 20-30 minutes by means of an oxygen-driven nebulizer. 
Ipratropium bromide should be added if there is a poor 
response to the initial doses of ß2 agonist, or on initial 
commencement of therapy if the attack is severe or life-
threatening (Figure 2).
Systemic corticosteroids should be administered early 
in the acute exacerbation.  The oral route is the preferred 
route of administration of corticosteroids.  Oral prednisone 
or prednisolone (1-2 mg/kg) should be given for three to 
five days. There is no need to taper the dose. Intravenous 
alternatives include hydrocortisone, methylprednisolone 
and dexamethasone.
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Figure 1: Mild-moderate asthma management
Mild-moderate asthma management
Mild-moderate Triage
Multidosing with salbutamol metered dose inhaler and spacer:
Age < 4: 6 puffs
Age > 4: 10 puffs
Administer 1 puff at a time via spacer allowing at least 6 breaths per puff.
Shake inhaler between each puff.






Observe for at least 2 hours.
Home with 5 days 
oral prednisolone, 
multidosing (maximum 4 hourly) and 
management plan.
Observe for at least 2 hours.
Home with 5 days
 oral prednisolone, 
multidosing (maximum 4 hourly) and 
management plan.
Observe for at least 12 hours.
Home with 5 days 
oral prednisolone, 
multidosing (maximum 4 hourly) and 
management plan.
No
Salbutamol metered dose inhaler multidosing:
6 or 10 puffs via spacer.
Admit to ward.
Continue salbutamol metered dose inhaler multidosing:  
6 or 10 puffs via spacer 
1-4 hourly depending on clinical condition
Monitor peak flow rates (age > 6).
Incomplete/poor response: Tachypnoea, wheezing, recessions, 
impaired speech or feeding, peak expiratory flow < 80%,  
saturation < 94% in room air.
Good response: No tachypnoea, minimal wheeze,
no recessions, able to speak and feed, peak expiratory  
flow > 80%, saturation > 94% in room air.
Consider discharge when patient has a good response and does not need metered dose inhaler and spacer more than 4 hourly.  






Severe asthma: One or more of following features:  
Cyanosis OR saturation < 94% OR previous intensive care unit 
admission OR drowsy or confused OR silent chest OR marked 
tachycardia OR pulsus paradoxus OR impaired speech or feeding 
OR peak expiratory flow < 60%.
Mild-moderate asthma: All of the features below:
No cyanosis, saturation > 94%, no previous intensive care unit 
admission, normal conscious level, good air entry, no marked 
tachycardia, no pulsus paradoxus, normal speech and feeding, 
peak expiratory flow > 60%.
Not improving: Discuss senior
Deterioration
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Incomplete/poor response: Tachypnoea, wheezing, recessions, 
impaired speech or feeding, peak expiratory flow < 80%,  
saturation < 94% in room air.
Good response: No tachypnoea, minimal wheezing,
no recessions, able to speak and feed, peak expiratory flow > 80%,
saturation > 94% in room air
Severe athma
Oxygen saturation ≤ 94%: Give oxygen via face mask and reservoir bag while preparing nebuliser.
Nebulise (together). Give 3 doses in first hour.
(3 doses may be completed on ward if improves during this time).
Oxygen flow rate > 6 l/minute.  Fill volume 4 ml using normal saline as diluent.  
Higher doses possible if minimal air entry.
1- 2 years: Salbutamol 5 mg/ml: 2.5 mg (½ ml) (or fenoterol 1 mg/ml: 0.5 mg; ½ ml) and ipratropium 0.25 mg/ml: 125 μg (½ ml). 
≥ 3 years: Salbutamol 5 mg/ml: 5 mg (1 ml) (or fenoterol 1 mg/ml: 1 mg; 1 ml) and ipratropium 0.25 mg/ml: 250 µg (1 ml). 
Site IV cannula.  Steroids for 5-7 days: Oral prednisolone (2 mg/kg, maximum dose 40 mg).
If vomiting/too unwell for oral medication: IVI dexamethasone 0.6 mg/kg daily until orals tolerated 
Improving Continuous saturation, heart  





Ipratropium bromide 4-6 hourly.
Improving
Not improving
Not improving.  





OR  CO2 > 6 
OR CO2 rising. 
Intensive care unit.6
Salbutamol load 
5-10 µg/kg/minute.7  




1-5 µg/kg/minute.8  
1 mg/ml solution 
at 0.06-0.3 ml/kg/hour.
High care.1
Continuous nebulised  
salbutamol 1 hour.2
AND/OR
Single dose intravenous 
salbutamol 15 µg/kg in 10 ml 
saline over 10 minutes.3
AND/OR
Single dose MgSO4 50% 
solution (2 mmol/ml)
0.1 ml/kg (50 mg/kg) 
(maximum 2 g) in 20 ml saline4 
over 20 minutes.5
Continue nebulised salbutamol 
every 20-30 minutes
for first 2 hours.
Wean salbutamol to 1-2 hourly 
depending on clinical response.
Ipratropium bromide 4-6 hourly.
Good response/stable
Convert to salbutamol
metered dose inhaler and spacer 




Severe asthma: One or more of following features: Cyanosis 
OR saturation < 94% OR previous intensive care unit admission 
OR drowsy or confused OR silent chest OR marked tachycardia 
OR pulsus paradoxus OR impaired speech or feeding, OR peak 
expiratory flow < 60%.
Mild-moderate asthma: All of the features below:
No cyanosis, saturation > 94%, no previous intensive care unit 
admission, normal conscious level, good air entry, no marked 
tachycardia, no pulsus paradoxus, normal speech and feeding, 
peak expiratory flow >  60%.
Notes
1. These may be commenced in the emergency department, should there be delay in transfer to 
the ward, providing the child is closely monitored.
2. Continuous nebulised salbutamol can be best achieved by refilling the nebuliser well using a 
cut feeding tube to prevent any disconnection of continuous oxygen delivery. Refill contents 
up to 6 ml when 2 ml remains.
3. Make up to a total volume of 10 ml and give through syringe driver at 60 ml/hour.
4. Make up to a total volume of 2 0ml and give through syringe driver at 60 ml/hour.
5. If intravenous magnesium has a good effect, a continuous infusion can be continued. Use 
MgSO4 50% solution (2 mmol/ml) at 0.06 ml/kg/hour (30mg/kg/hour) to keep Mg between 1.5 
and 2.3 mmol/l.
6. There is no role for aminophylline outside the intensive care unit (ICU). In ICU, it may 
occasionally have a role to play to prevent intubation if all other measures have failed.
7. Load children with salbutamol, even if they have already received the smaller single-dose 
intravenous salbutamol over 10 minutes.
8. A patient must be closely monitored during salbutamol infusion with K+ and lactic acidosis 
measured 6 hourly.
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Dehydration may occur because of poor fluid intake, 
sweating, and hyperventilation. Care should be taken not to 
overhydrate the child. It is best to provide only the normal 
fluid requirements for the child, usually in the form of a 
paediatric maintenance solution, or half-Darrow’s-dextrose 
given intravenously.
Further commonly used options include intravenous 
magnesium sulphate and intravenous salbutamol. 
Intravenous aminophylline is less commonly given due 
to the narrow therapeutic range and potential for severe 
side-effects. The management algorithm can be applied 
in most hospitals. If there are concerns about response to 
treatment, the child must be referred to a specialist centre 
for further management. 
No child should be discharged from hospital until recovery 
is adequate and the peak flow is above 80% of predicted.
Parental education and action plans
As with any long-term disease, the parent and the child 
should be educated about all aspects of asthma. Parents 
cannot be expected to follow a routine that involves the 
regular use of medication over a prolonged period if they do 
not understand why this is necessary. 
It is important to emphasise that children with asthma are 
able to lead a normal life with appropriate therapy. These 
children should be encouraged to participate in all sporting 
activities, particularly swimming. The primary care doctor 
should not hesitate to call in the specialist, social worker or 
psychologist if this is required in difficult cases.
An action plan should include instructions for both daily 
management (medication and environmental control 
measures) and guidelines on actions to manage worsening 
asthma. The plan should indicate the signs and symptoms 
used to recognise loss of asthma control, and what 
emergency and ongoing actions to take. Written asthma 
plans are particularly recommended for all patients on 
Level 2 or 3 therapy, and for those who have had a recent 
exacerbation, or who have poorly controlled asthma.  
The National Asthma Education programme (www.asthma.
co.za) provides free patient and doctor educational 
materials, and runs an asthma certificate course to teach 
doctors and nurses how to assess asthma, and to educate 
patients about how to use their medication to achieve 
optimum asthma control.
